Booster
Phase 1- Indications
- Acute myocardial infarction
Company intelligence / Profile preview
Intratech Medical has completed preclinical development of its Booster™ spiral balloon device for treating acute myocardial infarction. The product has demonstrated promising results in preclinical trials and is currently undergoing preliminary human studies in Israel and Europe[4]. The technology aims to reduce infarct size and improve cardiac outcomes after severe heart attacks by temporarily increasing coronary sinus pressure to enhance myocardial perfusion[1][3][4].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intratech Medical.